...
首页> 外文期刊>Clinical and experimental pharmacology & physiology >Co‐expression of LAG LAG 3 and TIM TIM 3 identifies a potent Treg population that suppresses macrophage functions in colorectal cancer patients
【24h】

Co‐expression of LAG LAG 3 and TIM TIM 3 identifies a potent Treg population that suppresses macrophage functions in colorectal cancer patients

机译:LAG LAG 3和TIM TIM 3的共同表达识别抑制结肠直肠癌患者中巨噬细胞功能的有效的Treg群体

获取原文
获取原文并翻译 | 示例

摘要

Summary Regulatory T (Treg) cells are critical suppressors of inflammation and are thought to exert mainly deleterious effects in cancers. In colorectal cancer ( CRC ), Foxp3 + Treg accumulation in tumors was associated with poor prognosis. Hence, we examined the circulating Treg cells in CRC patients. Compared to controls, CRC patients presented mild upregulations in CD 4 + CD 25 +/hi T cells and in the more canonical CD 4 + CD 25 +/hi Foxp3 + Treg cells in peripheral blood mononuclear cells. Both of these Treg populations could be roughly divided into lymphocyte activation gene 3 negative T cell immunoglobulin and mucin‐domain containing‐3 negative ( LAG 3 ? TIM 3 ? ) and LAG 3 + TIM 3 + subsets. In CRC patients, the LAG 3 + TIM 3 + subset represented approximately half of CD 4 + CD 25 +/hi T cells and greater than 60% of CD 4 + CD 25 +/hi Foxp3 + Treg cells, which was significantly more frequent than in healthy controls. Compared to the LAG 3 ? TIM 3 ? CD 4 + CD 25 +/hi T cells, the LAG 3 + TIM 3 + CD 4 + CD 25 +/hi T cells presented considerably higher transforming growth factor‐β and slightly higher interleukin ( IL )‐10 secretion, together with higher cytotoxic T‐lymphocyte associated protein 4 and Foxp3 expression levels. Notably, macrophages following incubation with LAG 3 ? TIM 3 ? CD 4 + CD 25 +/hi T cells and LAG 3 + TIM 3 + CD 4 + CD 25 +/hi T cells displayed different characteristics. Macrophages incubated with LAG 3 + TIM 3 + CD 4 + CD 25 +/hi T cells presented lower expression of major histocompatibility complex class II , CD 80, CD 86, and tumor necrosis factor‐α but higher expression of IL ‐10, than macrophages incubated with LAG 3 ? TIM 3 ? CD 4 + CD 25 +/hi T cells. Together, our investigations demonstrated that CRC patients presented an enrichment of circulating Treg cells, in which the LAG 3 + TIM 3 + subset exhibited more potent expression of inhibitory molecules, and furthermore, the LAG 3 + TIM 3 + Treg cells could suppress the proinflammatory activation of macrophages more potently than the LAG 3 ? TIM 3 ? Treg cells.
机译:发明内容调节性T(Treg)细胞是炎症的关键抑制剂,并且被认为在癌症中主要有害影响。在结直肠癌(CRC)中,肿瘤中的Foxp3 + Treg积累与预后差有关。因此,我们检查了CRC患者中的循环Treg细胞。与对照相比,CRC患者在CD 4 + Cd 25 + / HIT T细胞中呈现温和的上调,并在外周血单核细胞中更高的CD 4 + Cd 25 + / Hi Foxp3 + Treg细胞。这些Treg群体的两者可以大致分为淋巴细胞活化基因3阴性T细胞免疫球蛋白和含有-3负(LAG 3〜TIM 3?)和LAG 3 + TIM 3 +子集的粘液结构域。在CRC患者中,LAG 3 + TIM 3 +子集代表CD 4 + CD 25 + / HI T细胞的大约一半,大于60%的CD 4 + Cd 25 + / Hi Foxp3 + Treg细胞,其显着更频繁而不是健康的对照。与滞后3相比?蒂姆3? CD 4 + Cd 25 + / Hi T细胞,LAG 3 + TIM 3 + CD 4 + CD 25 + / HI T细胞呈现出相当高的转化生长因子-β和稍高的白细胞介素(IL)-10分泌,以及更高细胞毒性T淋巴细胞相关蛋白4和FOXP3表达水平。值得注意的是,与滞后3孵育后巨噬细胞?蒂姆3? CD 4 + Cd 25 + / Hi T细胞和LAG 3 + TIM 3 + CD 4 + CD 25 + / HI T细胞显示不同的特性。用LAG孵育的巨噬细胞3 + TIM 3 + CD 4 + CD 25 + / HI T细胞呈现出主要组织相容性综合体II,CD 80,CD 86和肿瘤坏死因子-α但高于IL -10的表达的较低表达,而不是巨噬细胞与滞后3孵育?蒂姆3? CD 4 + CD 25 + / HI T细胞。我们的研究表明,CRC患者呈现循环Treg细胞的富集,其中LAG 3 + TIM 3 +子集表现出更有效的抑制分子表达,而且,LAG 3 + TIM 3 + Treg细胞可以抑制促炎激活巨噬细胞比滞后3更有效吗?蒂姆3? Treg细胞。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号